The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index.


Updates from The Motley Fool

Latest updates on SPDR S&P Pharmaceuticals from Fool.com.
These 3 ETFs Jumped in November

Even as the stock market put in a tepid performance, these ETFs managed to produce sizable gains....



Stock Performance

View Interactive XPH Charts
Sponsored by

Key Data Points

Primary metrics and data points about SPDR S&P Pharmaceuticals.
Current Price: $42.80
Prev Close: $42.18
Open: $42.27
Bid: $42.72
Ask: $43.64
Day's Range: $42.27 - $42.97
52wk Range: $36.58 - $47.82
Volume: 69,747
Avg Vol 120,491
Market Cap: $467M
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.11 (0.6%)

Company Rating

What our community thinks about SPDR S&P Pharmaceuticals.
CAPS Rating 2 out of 5
 
28 Outperform
7 Underperform
CAPS All Stars
 
4 Outperform
2 Underperform

How do you think SPDR S&P Pharmaceuticals will perform against the market?



You pick for SPDR S&P Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for SPDR S&P Pharmaceuticals.

The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index.

  • Exchange: NYSEMKT
  • Sector: Sector Equity
  • Industry: Health/Biotechnology Funds